DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-36.69%
US · US
EME.US latest organized financial period shows revenue grew +16.62% YoY and net income grew +26.38% YoY. Current price is about 845 USD, while the model base case is about 555 USD; the current price sits +52.2% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:27
Hover each model row to inspect formulas and inputs.
+52.22%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-36.69%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-1.21%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 10.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
+232%
Updated: 2026/04/29 15:27
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| 2025/12/31 | Business sale gain/loss | Asset sale gain/loss | 114M USD | Medium |
| 2024/12/31 | Asset sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -6M USD | Medium |
| 2023/12/31 | Asset sale gain/loss | Asset sale gain/loss | 5M USD | Medium |
| 2022/12/31 | Asset sale gain/loss | Asset sale gain/loss | 15M USD | Medium |
| 2021/12/31 | Asset sale gain/loss | Asset sale gain/loss | 2M USD | Medium |
| 2020/12/31 | Asset impairment | Impairment | -552M USD | Medium |
| 2020/12/31 | Asset sale gain/loss | Asset sale gain/loss | 289K USD | Medium |
| 2020/12/31 | Restructuring charges | Restructuring | -5M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | 17B USD | 1B USD | 1B USD | 1B USD | 28.19 | 25.62 |
| 2024/12/31 | Annual | 15B USD | 1B USD | 1B USD | 1B USD | 21.52 | 21.49 |
| 2023/12/31 | Annual | 13B USD | 633M USD | 634M USD | 900M USD | 13.31 | 13.32 |
| 2022/12/31 | Annual | 11B USD | 406M USD | 391M USD | 498M USD | 8.1 | 7.8 |
| 2021/12/31 | Annual | 10B USD | 384M USD | 382M USD | 319M USD | 7.06 | 7.03 |
Total revenue recognized in each fiscal year.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.